College of Medicine

Medicine & Life Sciences

1. Neoplasms 100%
2. Therapeutics 79%
3. Multicenter Studies 74%
4. Survival 73%
5. Confidence Intervals 72%
6. Breast Neoplasms 68%
7. Population 61%
8. Recurrence 59%
9. Cohort Studies 57%
10. Odds Ratio 56%
11. Genes 53%
12. Serum 51%
13. Kidney 51%
14. Tomography 50%
15. Lung 50%
16. Safety 50%
17. Stroke 47%
18. Neoplasm Metastasis 46%
19. Mortality 46%
20. Mutation 42%
21. Brain 42%
22. Stomach Neoplasms 42%
23. Elderly 42%
24. Child 41%
25. Chronic Obstructive Pulmonary Disease 41%
26. Incidence 41%
27. Mesenchymal Stem Cells 40%
28. Breast 40%
29. Prospective Studies 40%
30. Retrospective Studies 39%
31. Meta-Analysis 39%
32. Liver 39%
33. Hepatocellular Carcinoma 39%
34. Drug Therapy 38%
35. Radiotherapy 38%
36. Palatine Tonsil 37%
37. Atrial Fibrillation 37%
38. Lymph Nodes 36%
39. Magnetic Resonance Imaging 36%
40. Wounds and Injuries 35%
41. Guidelines 34%
42. Blood Pressure 33%
43. Proteins 33%
44. Colorectal Neoplasms 33%
45. Apoptosis 32%
46. Skin 32%
47. Seoul 31%
48. Body Mass Index 31%
49. Bone and Bones 31%
50. Pain 30%
51. Cognitive Dysfunction 30%
52. Randomized Controlled Trials 29%
53. Phosphorylation 29%
54. Shoulder 29%
55. Endothelial Cells 29%
56. Transplants 28%
57. Hypertension 28%
58. Asthma 28%
59. Alzheimer Disease 28%
60. Uric Acid 28%
61. Non-Small Cell Lung Carcinoma 27%
62. Single Nucleotide Polymorphism 27%
63. Nutrition Surveys 27%
64. Uterine Cervical Neoplasms 27%
65. Survival Rate 26%
66. Biomarkers 26%
67. Metabolic Syndrome 26%
68. Registries 26%
69. Inflammation 26%
70. Infections 26%
71. Chemoradiotherapy 26%
72. Messenger RNA 25%
73. Genotype 25%
74. Blood Vessels 25%
75. Health 25%
76. Knee 25%
77. Stomach 25%
78. Parkinson Disease 24%
79. Regression Analysis 24%
80. Pregnancy 24%
81. Multivariate Analysis 24%
82. Fluorodeoxyglucose F18 24%
83. Ultrasonography 24%
84. Anti-Inflammatory Agents 24%
85. Obesity 24%
86. Colonoscopy 24%
87. Mothers 24%
88. Lipopolysaccharides 24%
89. Injections 24%
90. Carcinoma 23%
91. Knee Replacement Arthroplasties 23%
92. Serogroup 23%
93. Biopsy 23%
94. Control Groups 23%
95. Robotics 23%
96. Liver Transplantation 23%
97. Hip 22%
98. Growth 22%
99. Cytokines 22%
100. Thigh 22%